| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received November 13, 2001
Accepted after revision January 15, 2002
1 Division of Neuroscience, John Curtin School of Medical Research, Australian National University, GPO Box 334, Canberra, ACT, Australia, 2601
2 Department of Zoology, University of Melbourne, Parkville, Victoria 3052, Australia
3 Division of Neuroscience, John Curtin School of Medical Research, Australian National University, GPO Box 334, Canberra, ACT, 2601 and *Department of Zoology, University of Melbourne, Parkville, Victoria 3052, Australia
* To whom correspondence should be addressed. E-mail: rebecca.haddock{at}anu.edu.au.
The cellular mechanisms underlying vasomotion of irideal arterioles from juvenile rats have been studied using electrophysiological methods, ratiometric calcium measurements and video microscopy. Vasomotion was not affected by removal of the endothelium. Spontaneous contractions were preceded by spontaneous depolarizations. Both were abolished by the intracellular calcium chelator, BAPTA-AM (20 µm), but not by ryanodine (10 µm), suggesting a dependence on the cyclical release of calcium from intracellular stores, other than those operated by ryanodine receptors. Oscillations were little changed when the membrane potential of short segments of arteriole was either depolarized or hyperpolarized. When the segments were voltage clamped, oscillating inward currents were recorded, indicating that the changes in membrane were voltage independent. Vasomotion was preceded by intracellular calcium oscillations and both were abolished by inhibitors of phospholipase C (U73122, 10 µm), phospholipase A2 (AACOCF3, 30 µm) and protein kinase C (chelerythrine chloride, 5 µm, and myristoylated protein kinase C peptide, 10 µm). Inhibition of vasomotion by the dual lipoxygenase and cyclo-oxygenase inhibitor, NDGA (10 µm), the lipoxygenase inhibitor, ETI (1 µm) but not by the cyclo-oxygenase inhibitors, aspirin (10 µm) and indomethacin (10 µm), or the cytochrome P450 inhibitor 17-ODYA (10 µm), suggested an involvement of the lipoxygenase pathway. The observations suggest that vasomotion of iris arterioles is voltage independent and results from the cyclical release of calcium from IP3-sensitive stores which are activated by cross talk between the phospholipase C and phospholipase A2 pathways in vascular smooth muscle.
This article has been cited by other articles:
|
|
 |
|
  J. C. B. Jacobsen, C. Aalkjaer, H. Nilsson, V. V. Matchkov, J. Freiberg, and N.-H. Holstein-Rathlou Activation of a cGMP-sensitive calcium-dependent chloride channel may cause transition from calcium waves to whole cell oscillations in smooth muscle cells Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H215 - H228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. B. Jacobsen, C. Aalkjaer, H. Nilsson, V. V. Matchkov, J. Freiberg, and N.-H. Holstein-Rathlou A model of smooth muscle cell synchronization in the arterial wall Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H229 - H237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Imtiaz, J. Zhao, K. Hosaka, P.-Y. von der Weid, M. Crowe, and D. F. van Helden Pacemaking through Ca2+ Stores Interacting as Coupled Oscillators via Membrane Depolarization Biophys. J., June 1, 2007; 92(11): 3843 - 3861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Haddock, T. H. Grayson, T. D. Brackenbury, K. R. Meaney, C. B. Neylon, S. L. Sandow, and C. E. Hill Endothelial coordination of cerebral vasomotion via myoendothelial gap junctions containing connexins 37 and 40 Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2047 - H2056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Beny, M. Koenigsberger, and R. Sauser Role of myoendothelial communication on arterial vasomotion Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2036 - H2038. [Full Text] [PDF]
|
|
|
|
|
|
M. Koenigsberger, R. Sauser, J.-L. Beny, and J.-J. Meister Effects of Arterial Wall Stress on Vasomotion Biophys. J., September 1, 2006; 91(5): 1663 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E Haddock and C. E Hill Rhythmicity in arterial smooth muscle J. Physiol., August 1, 2005; 566(3): 645 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koenigsberger, R. Sauser, J.-L. Beny, and J.-J. Meister Role of the Endothelium on Arterial Vasomotion Biophys. J., June 1, 2005; 88(6): 3845 - 3854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koenigsberger, R. Sauser, M. Lamboley, J.-L. Beny, and J.-J. Meister Ca2+ Dynamics in a Population of Smooth Muscle Cells: Modeling the Recruitment and Synchronization Biophys. J., July 1, 2004; 87(1): 92 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lamboley, A. Schuster, J.-L. Beny, and J.-J. Meister Recruitment of smooth muscle cells and arterial vasomotion Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H562 - H569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nilsson and C. Aalkjaer Vasomotion: Mechanisms and Physiological Importance Mol. Interv., March 1, 2003; 3(2): 79 - 89. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
